ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

TVTX Travere Therapeutics Inc

6,80
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:09:45
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Travere Therapeutics Inc TVTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 6,80 10:09:45
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,80
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.5.202423:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
13.5.202422:05EDGAR2Form 8-K - Current report
10.5.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.5.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.5.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.5.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.5.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.5.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.5.202422:30GLOBETravere Therapeutics to Present at National Kidney..
08.5.202422:30GLOBETravere Therapeutics to Present at Upcoming Investor..
06.5.202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.5.202422:05EDGAR2Form 8-K - Current report
06.5.202422:01GLOBETravere Therapeutics Reports First Quarter 2024 Financial..
29.4.202422:30GLOBETravere Therapeutics to Report First Quarter 2024 Financial..
24.4.202413:05GLOBETravere Therapeutics and CSL Vifor Announce European..
24.4.202409:00PRNCACSL Vifor and Travere Therapeutics Announce European..
04.4.202422:30GLOBETravere Therapeutics to Present Abstracts at the Society for..
03.4.202422:30GLOBETravere Therapeutics to Present Abstracts on FILSPARI®..
13.3.202422:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
11.3.202412:05GLOBETravere Therapeutics Submits Supplemental New Drug..
26.2.202422:30GLOBETravere Therapeutics to Present at Upcoming Investor..
23.2.202422:05EDGAR2Form 8-K - Current report
23.2.202413:05GLOBETravere Therapeutics and CSL Vifor Announce Sparsentan..
23.2.202408:00PRNCACSL Vifor and Travere Therapeutics announce sparsentan..
20.2.202414:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15.2.202422:05EDGAR2Form 8-K - Current report
15.2.202422:01GLOBETravere Therapeutics Reports Fourth Quarter and Full Year..
14.2.202420:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202422:30GLOBETravere Therapeutics to Report Fourth Quarter and Full Year..
02.2.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202403:58EDGAR2Form 144 - Report of proposed sale of securities
02.2.202403:58EDGAR2Form 144 - Report of proposed sale of securities
02.2.202403:57EDGAR2Form 144 - Report of proposed sale of securities
01.2.202422:30GLOBETravere Therapeutics to Present at the Guggenheim 6th Annual..
01.2.202418:44EDGAR2Form 144 - Report of proposed sale of securities
01.2.202415:52EDGAR2Form 144 - Report of proposed sale of securities
25.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:05GLOBETravere Therapeutics Announces Licensing Agreement with..
23.1.202419:17EDGAR2Form 144 - Report of proposed sale of securities
23.1.202416:51EDGAR2Form 144 - Report of proposed sale of securities
08.1.202413:07EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock